| [1] |
Zhang Rui, Chu Yanliu.
Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota
[J]. Journal of International Oncology, 2024, 51(6): 370-375.
|
| [2] |
Gao Fan, Wang Ping, Du Chao, Chu Yanliu.
Research progress on intestinal flora and non-surgical treatment of the colorectal cancer
[J]. Journal of International Oncology, 2024, 51(6): 376-381.
|
| [3] |
Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.
Effect of cancer nodules on liver metastases after radical resection of colorectal cancer
[J]. Journal of International Oncology, 2024, 51(5): 280-285.
|
| [4] |
Sun Guobao, Yang Qian, Zhuang Qingchun, Gao Binbin, Sun Xiaogang, Song Wei, Sha Dan.
Research progress on the histopathological growth patterns of colorectal liver metastasis
[J]. Journal of International Oncology, 2024, 51(2): 114-118.
|
| [5] |
Liu Debao, Sun Ziwen, Lu Shoutang, Xu Haidong.
Expression and clinical significance of ASB6 in colorectal cancer tissues
[J]. Journal of International Oncology, 2023, 50(8): 470-474.
|
| [6] |
Chen Zhuo, Tao Jun, Chen Lin, Ke Jing.
Value of detection of peripheral blood miR-194 combined with fecal miR-143 in the clinical screening of colorectal cancer
[J]. Journal of International Oncology, 2023, 50(5): 268-273.
|
| [7] |
Huang Zhen, Zhang Caiyutian, Ke Shaobo, Shi Wei, Zhao Wensi, Chen Yongshun.
Construction of postoperative prognosis model for patients with colorectal cancer
[J]. Journal of International Oncology, 2023, 50(3): 157-163.
|
| [8] |
Xu Liangfu, Li Yuanfei.
Research progress on tumor microenvironment and immune combination therapy of MSS colorectal cancer
[J]. Journal of International Oncology, 2023, 50(3): 186-190.
|
| [9] |
Liu Yujie, Zhao Zhiqiang, Wang Zicheng.
Levels and diagnostic value of TOP2A and ERBB2 in peripheral blood mononuclear cells of patients with early colorectal cancer
[J]. Journal of International Oncology, 2023, 50(12): 717-722.
|
| [10] |
Tao Hong, Yin Hong, Luo Hong, Tao Jiayu.
Potential strategies for targeting tumor-associated macrophages to enhance the efficacy of immune checkpoint inhibitors for colorectal cancer
[J]. Journal of International Oncology, 2023, 50(11): 683-687.
|
| [11] |
Wang Xi, Wu Chuanqing.
Research progress in reversing multidrug resistance in colorectal cancer
[J]. Journal of International Oncology, 2023, 50(1): 42-46.
|
| [12] |
Gao Yizhao, Liu Yang, Liu Qiulong, Xing Jinliang.
Application of circulating cell-free nucleic acid in clinical diagnosis and treatment of colorectal cancer
[J]. Journal of International Oncology, 2022, 49(9): 555-559.
|
| [13] |
He Zhefeng, Wu Yiyang, Li Zhenjun, Ying Xiaojiang.
Predictive value of inflammatory markers in colorectal cancer
[J]. Journal of International Oncology, 2022, 49(9): 560-563.
|
| [14] |
Zhao Ying, Zhang Gehong.
Study on the correlations between AGR, PLR and NLR changes and chemotherapy efficacy of metastatic colorectal cancer
[J]. Journal of International Oncology, 2022, 49(8): 473-477.
|
| [15] |
Huang Mengpan, Wang Xuehong, Lu Yongfu.
Mechanism of FOXA2 in colorectal cancer and its application in diagnosis and treatment
[J]. Journal of International Oncology, 2022, 49(8): 490-493.
|
